Changeflow GovPing Courts & Legal MYMEDONE Opposition Dismissed Without Prejudice...
Routine Enforcement Amended Final

MYMEDONE Opposition Dismissed Without Prejudice - Med One Capital Funding LLC v MedOne LC

Favicon for changeflow.com TTAB Proceedings
Filed
Detected
Email

Summary

The Trademark Trial and Appeal Board dismissed Opposition No. 91299302 filed by Med One Capital Funding, LLC against MedOne, L.C.'s MYMEDONE trademark application. The opposition was dismissed without prejudice, meaning the plaintiff may potentially refile or pursue other remedies. The MYMEDONE mark remains in contention. The proceeding was filed on May 28, 2025, and the Board's decision issued on April 26, 2026.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors TTAB Proceedings for new courts & legal regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 106 changes logged to date.

What changed

The TTAB issued a Board Decision in Opposition No. 91299302, dismissing Med One Capital Funding, LLC's opposition to the MYMEDONE trademark application filed by MedOne, L.C. The dismissal was entered without prejudice, meaning the opposition proceeding concluded but the underlying trademark application may proceed or the opposer may pursue alternative avenues. No monetary penalties or sanctions were imposed.

Parties involved in trademark opposition proceedings should note that a dismissal without prejudice does not preclude future related actions. The opposer retains potential remedies including refiling the opposition if new grounds become available or pursuing federal court action under Section 21 of the Trademark Act. The MYMEDONE mark's ultimate registrability remains unresolved by this decision.

Archived snapshot

Apr 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO TTAB Proceedings

Opposition: MYMEDONE

Opposition TTAB91299302-20260426 Kind: OPP Apr 26, 2026

Abstract

BD DECISION: OPP DISMISSED W/O PREJ
Plaintiff: Med One Capital Funding, LLC
Defendant: MedOne, L.C.
Mark at issue: MYMEDONE

Filing Date

2025-05-28

View original document →

Get daily alerts for TTAB Proceedings

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Filed
April 26th, 2026
Instrument
Enforcement
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Docket
91299302

Who this affects

Applies to
Legal professionals Plaintiffs Defendants
Industry sector
5239 Asset Management
Activity scope
Trademark opposition Administrative adjudication IP litigation
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Financial Services

Get alerts for this source

We'll email you when TTAB Proceedings publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!